题目:Intestinal modulation of metabolic disease: discovery of new drug targets
报告人: Frank J Gonzalez教授，美国国立卫生研究院
主持人: 毕惠嫦 教授，中山大学药学院
Dr. Gonzalez is chief of Laboratory of Metabolism, National Cancer Institute, National Institutes of Health. He has more than 40 years of research experience in the study of drug and carcinogen metabolism, and in determining mechanisms of chemical carcinogenesis, primarily using mouse models, molecular biological techniques, and metabolomics strategies.
Till now, he has published more than 1100 papers that received more than 82,000 citations (h-index 142) in journals including Science, Nature, Nature Medicine, Nature Communications, PNAS, Cell Metabolism, Journal of Clinical Investigation, and Hepatology etc. He is co-inventor on more than 20 US patents, has served as a board member of various pharmacological, biochemical, toxicological, and pharmaceutical associations or societies, and on the editorial board of a number of journals, and also provided consulting activities for the pharmaceutical industry. To date, he has more than 30 awards or special scientific recognition from various professional societies and associations. He has delivered more than 400 scientific talks or seminars all over the world.